Emerging studies areing on Nexaph amino acid sequences, a distinct class of agents showing significant capability for affecting multiple disease pathways. Compared to existing small molecule approaches, these peptides present enhanced selectivity and reduced unintended consequences, allowing them a truly desirable pathway for next-generation therap